Clinical Trial Update: ABT-751 in Treating Young Patients With Refractory Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of ABT-751 in children with refractory solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Extragonadal Germ Cell Tumor
• Germ Cell Tumor
• Kidney Cancer
• Liver Cancer
• Neuroblastoma
• Ovarian Cancer
• Sarcoma

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: COMPLETED